Stryker Corporation SYK
272.36
2.61
0.97%
as of 25 Sep
- Market cap
- $103.9B
- P/E
- 28.0×
Follow SYK
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Stryker Corporation (SYK) Return on equity
Stryker Corporation's return on equity over the twelve months to 30 June 2026 was 16.5%, up 1.4 percentage points from fiscal 2025 (15.1%). Over the past ten years it has ranged from 10.5% (fiscal 2017) to 32.7% (fiscal 2018); the current reading is higher than 45% of that period. That is above the Medical Devices industry median of −15.3% and above the Healthcare sector median of −32.0%.
Return on equity, annual
Annual
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 15.1% | (0.18) |
| FY2024 | 15.3% | (2.72) |
| FY2023 | 18.0% | 3.01 |
| FY2022 | 15.0% | 0.71 |
| FY2021 | 14.3% | 1.91 |
| FY2020 | 12.4% | (4.63) |
| FY2019 | 17.0% | (15.75) |
| FY2018 | 32.7% | 22.28 |
| FY2017 | 10.5% | (7.79) |
| FY2016 | 18.2% | 1.42 |
Against its own ten years
Low 10.5%
High 32.7%
Ten-year median
15.3%
Current reading's percentile
45
Return on equity against peers
| Company | Return on equity |
|---|---|
| DXCM DexCom, Inc. compare | 38.5% |
| GEHC GE HealthCare Technologies Inc. compare | 19.2% |
| SYK Stryker Corporation | 16.5% |
| BSX Boston Scientific Corporation compare | 15.4% |
| STE STERIS plc compare | 11.4% |
| ABT Abbott Laboratories compare | 10.6% |
| MDT Medtronic PLC compare | 10.6% |
| PHG Koninklijke Philips N.V. compare | 10.2% |
| EW Edwards Lifesciences Corporation compare | 9.42% |
| Medical Devices industry median | −15.3% |
| Healthcare sector median | −32.0% |
| Market median | 1.76% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on SYK
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement